News | CT Angiography (CTA) | November 19, 2026

Siemens Healthineers' Syngo.CT Coronary Cockpit Arterial Disease Management Software Gets FDA Clearance

The software provides AI-powered plaque analysis and PCI planning with coronary CT imaging. It also quantifies and qualifies plaque burden for clinical decision-making.

Siemens Healthineers' Syngo.CT Coronary Cockpit Arterial Disease Management Software Gets FDA Clearance

Photo: Siemens Healthineers


Nov. 19, 2026 — Siemens Healthineers has received clearance from the Food and Drug Administration for Syngo.CT Coronary Cockpit, a new software solution that supports management of coronary artery disease (CAD) using coronary computed tomography angiography (CCTA) data. Syngo.CT Coronary Cockpit provides advanced, automated analysis of coronary plaque, enabling access to critical details in cardiac CT images to support clinical decision-making and percutaneous coronary intervention (PCI) planning.

“With Syngo.CT Coronary Cockpit, clinicians can obtain advanced insights from a patient’s CT scan to support a more comprehensive assessment of cardiac health and better inform treatment decisions, ultimately helping people with coronary artery disease live longer, healthier lives,” said Olivia Egan, head of Computed Tomography at Siemens Healthineers North America.

Coronary artery disease is the most common form of heart disease, which is the leading cause of death in the U.S. and around the world.¹ Patients with suspected or known CAD often undergo invasive diagnostic procedures in the cath lab that could have been avoided with additional information. Noninvasive CCTA has become a frontline diagnostic tool due to advances in dual-source and photon-counting CT technology. Using CCTA with the dual-source Naeotom Alpha photon-counting CT scanner from Siemens Healthineers can reduce diagnostic angiography referrals by more than 50% as well as lower costs and shorten hospital stays², due to CCTA’s value in assessing plaque visibility.

Syngo.CT Coronary Cockpit, which resides within the Syngo.via imaging software platform, uses AI-based segmentation, labeling, and visualization to characterize the amount and morphology of a patient’s plaque across the entire coronary tree or within individual lesions. This detailed information regarding plaque composition, size, and distribution can help clinicians better assess patient risk and determine whether intervention or medical management is appropriate.

Syngo.CT Coronary Cockpit is designed to support clinical decision-making and workflow efficiency across the CAD care pathway using CCTA data from any CT scanner. Integration with Siemens Healthineers dual-source and photon-counting CT systems provides additional benefits through the high native temporal resolution of dual-source technology and the ultra-high spatial resolution provided by the Naeotom Alpha class.

  1. U.S. Centers for Disease Control & Prevention
  2. https://doi.org/10.1148/radiol.231234, https://doi.org/10.1148/ryct.230022

 

Siemens Syngo FDA

 

FDA


Additional Content

News | Heart Failure

Nov. 12, 2026 — Ventric Health and Stellus Rx have announced a strategic collaboration designed to solve one of primary ...

Home November 13, 2026
Home
News | Heart Failure

Oct. 14, 2026 — GLP-1 weight loss drugs known may help protect against heart failure even at doses too low to produce ...

Home October 19, 2026
Home
Feature | Heart Failure | Kyle Hardner

The shift toward steering appropriate cardiovascular cases to outpatient settings is gaining momentum, driven by a ...

Home September 11, 2026
Home
News | Heart Failure

Sept. 9, 2026— Atman Health has been selected by the Advanced Research Projects Agency for Health (ARPA-H) to develop an ...

Home September 11, 2026
Home
News | Heart Failure

Aug. 31, 2026 — A new heart failure (HF) treatment effect calculator could help overcome one of the largest barriers to ...

Home August 31, 2026
Home
Subscribe Now